LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $199,000 | -12.7% | 2,000 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $228,000 | +0.4% | 2,000 | +10.6% | 0.01% | 0.0% |
| Q1 2019 | $227,000 | -7.3% | 1,808 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $245,000 | -50.6% | 1,808 | 0.0% | 0.01% | -40.0% |
| Q3 2018 | $496,000 | +35.9% | 1,808 | +2.7% | 0.01% | +25.0% |
| Q2 2018 | $365,000 | -31.4% | 1,760 | -50.0% | 0.01% | +33.3% |
| Q1 2018 | $532,000 | +120.7% | 3,520 | +100.0% | 0.01% | +20.0% |
| Q4 2017 | $241,000 | +28.9% | 1,760 | +27.9% | 0.01% | +25.0% |
| Q3 2017 | $187,000 | +39.6% | 1,376 | +24.6% | 0.00% | +33.3% |
| Q2 2017 | $134,000 | +112.7% | 1,104 | +86.5% | 0.00% | +50.0% |
| Q1 2017 | $63,000 | +28.6% | 592 | +23.3% | 0.00% | +100.0% |
| Q4 2016 | $49,000 | – | 480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |